viernes, 21 de diciembre de 2018

Phase 2 Cystic Fibrosis Trial Testing Investigational MS1819-SD Begins

Phase 2 Cystic Fibrosis Trial Testing Investigational MS1819-SD Begins

Cystic Fibrosis News Today

AzurRx Starts Phase 2 Clinical Trial Testing MS1819-SD in CF Patients With EPI

No hay comentarios:

Publicar un comentario